144 related articles for article (PubMed ID: 12213292)
1. Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan.
Yoneda K; Tanji Y; Ikeda N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2002 Dec; 186(2):223-30. PubMed ID: 12213292
[TBL] [Abstract][Full Text] [Related]
2. Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients.
Marttunen MB; Hietanen P; Tiitinen A; Ylikorkala O
J Clin Endocrinol Metab; 1998 Apr; 83(4):1158-62. PubMed ID: 9543133
[TBL] [Abstract][Full Text] [Related]
3. The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men.
Välimäki VV; Piippo K; Välimäki S; Löyttyniemi E; Kontula K; Välimäki MJ
Osteoporos Int; 2005 Dec; 16(12):1633-40. PubMed ID: 15827868
[TBL] [Abstract][Full Text] [Related]
4. Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer.
Zidan J; Keidar Z; Basher W; Israel O
Med Oncol; 2004; 21(2):117-21. PubMed ID: 15299183
[TBL] [Abstract][Full Text] [Related]
5. Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230).
Eastell R; Hannon RA; Cuzick J; Dowsett M; Clack G; Adams JE;
J Bone Miner Res; 2006 Aug; 21(8):1215-23. PubMed ID: 16869719
[TBL] [Abstract][Full Text] [Related]
6. Effects of exemestane, anastrozole and tamoxifen on bone mineral density and bone turnover markers in postmenopausal early breast cancer patients: results of N-SAS BC 04, the TEAM Japan substudy.
Aihara T; Suemasu K; Takei H; Hozumi Y; Takehara M; Saito T; Ohsumi S; Masuda N; Ohashi Y
Oncology; 2010; 79(5-6):376-81. PubMed ID: 21430407
[TBL] [Abstract][Full Text] [Related]
7. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE
J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845
[TBL] [Abstract][Full Text] [Related]
8. Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane.
Gonnelli S; Cadirni A; Caffarelli C; Petrioli R; Montagnani A; Franci MB; Lucani B; Francini G; Nuti R
Bone; 2007 Jan; 40(1):205-10. PubMed ID: 16904960
[TBL] [Abstract][Full Text] [Related]
9. Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.
Coleman RE; Banks LM; Girgis SI; Kilburn LS; Vrdoljak E; Fox J; Cawthorn SJ; Patel A; Snowdon CF; Hall E; Bliss JM; Coombes RC;
Lancet Oncol; 2007 Feb; 8(2):119-27. PubMed ID: 17267326
[TBL] [Abstract][Full Text] [Related]
10. A TA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first exon and intron are not.
Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
J Bone Miner Res; 2000 Nov; 15(11):2222-30. PubMed ID: 11092403
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor alpha and vitamin D receptor gene polymorphisms and bone mineral density: association study of healthy pre- and postmenopausal Chinese women.
Zhang YY; Long JR; Liu PY; Liu YJ; Shen H; Zhao LJ; Deng HW
Biochem Biophys Res Commun; 2003 Sep; 308(4):777-83. PubMed ID: 12927786
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density.
Gennari L; Becherini L; Masi L; Mansani R; Gonnelli S; Cepollaro C; Martini S; Montagnani A; Lentini G; Becorpi AM; Brandi ML
J Clin Endocrinol Metab; 1998 Mar; 83(3):939-44. PubMed ID: 9506753
[TBL] [Abstract][Full Text] [Related]
13. Association of estrogen receptor β and estrogen-related receptor α gene polymorphisms with bone mineral density in postmenopausal women.
Shoukry A; Shalaby SM; Etewa RL; Ahmed HS; Abdelrahman HM
Mol Cell Biochem; 2015 Jul; 405(1-2):23-31. PubMed ID: 25903400
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor alpha gene polymorphisms and bone mineral density: haplotype analysis in women from the United Kingdom.
Albagha OM; McGuigan FE; Reid DM; Ralston SH
J Bone Miner Res; 2001 Jan; 16(1):128-34. PubMed ID: 11149476
[TBL] [Abstract][Full Text] [Related]
15. Effects of tamoxifen and toremifene on urinary excretion of pyridinoline and deoxypyridinoline and bone density in postmenopausal patients with breast cancer.
Marttunen MB; Hietanen P; Titinen A; Roth HJ; Viinikka L; Ylikorkala O
Calcif Tissue Int; 1999 Nov; 65(5):365-8. PubMed ID: 10541761
[TBL] [Abstract][Full Text] [Related]
16. Genetic effects of estrogen receptor alpha and collagen IA1 genes on the relationships of parathyroid hormone and 25 hydroxyvitamin D with bone mineral density in Caucasian women.
Sapir-Koren R; Livshits G; Kobyliansky E
Metabolism; 2003 Sep; 52(9):1129-35. PubMed ID: 14506618
[TBL] [Abstract][Full Text] [Related]
17. Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years.
Love RR; Barden HS; Mazess RB; Epstein S; Chappell RJ
Arch Intern Med; 1994 Nov; 154(22):2585-8. PubMed ID: 7979855
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women.
Mizunuma H; Hosoi T; Okano H; Soda M; Tokizawa T; Kagami I; Miyamoto S; Ibuki Y; Inoue S; Shiraki M; Ouchi Y
Bone; 1997 Nov; 21(5):379-83. PubMed ID: 9356730
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor gene polymorphisms and bone mineral density in Chinese postmenopausal women.
Liu J; Zhu H; Zhu X; Dai M; Jiang L; Xu M; Chen J
Chin Med J (Engl); 2003 Mar; 116(3):364-7. PubMed ID: 12781038
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor beta gene polymorphisms are associated with higher bone mineral density in premenopausal, but not postmenopausal southern Chinese women.
Lau HH; Ho AY; Luk KD; Kung AW
Bone; 2002 Aug; 31(2):276-81. PubMed ID: 12151079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
